Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Pakistan

Medicine Sales To Exceed US$2bn Within A Decade

April 2010 | Industry Trend Analysis

Combined sales of prescription drugs and over-the-counter (OTC) medicines in Pakistan are forecast to increase from PKR132bn (US$1.62bn) in 2009 to PKR144bn (US$1.64bn) in 2010. Due to the weakening rupee, this equates to growth of 9.1% in local currency terms and 1.2% in US dollar

To read the full article, please sign in or take a free trial.

Related Insight Articles
Searle Pakistan Looks Overseas For Growth

Industry / Pakistan BMI believes the strategy adopted by Searle Pakistan is advisable given the challenging operating environment in the South Asian country. The Karachi-based drugmaker dramatically boosted exports to frontier...
April 2010
Pharmaceutical Market Evolving Slowly

Industry / Pakistan Pakistan's US$1.62bn pharmaceutical market is the 10th largest in Asia Pacific, behind the Philippines (US$2.58bn) and ahead of Vietnam (US$1.53bn). Annual per-capita spending on medicines is US$10, which...
April 2010
Healthcare Spending To Reach US$5.26bn By 2014

Industry / Pakistan Healthcare spending in Pakistan is expected to increase from PKR227bn (US$2.76bn) in 2009 to PKR257bn (US$2.86bn) in 2010. Due to depreciation of the rupee, this equates to growth of 3.6% in US dollar...
January 2010
New Medicine Pricing Rules Unveiled

Industry / Pakistan The pharmaceutical pricing regime in Pakistan is typical of an emerging market and far below international standards. Both generic drugs and patented products are subject to price controls. The maximum...
January 2010
Drug Market Forecast Increased

Companies / Pakistan BMI has upwardly revised its projections for the Pakistan pharmaceutical market after new figures for 2007 were revealed at the Pak Pharma Expo. The market is currently valued at PKR90bn (US$1.48bn),...
April 2007


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2010 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS